American Labs names Dr. Richard S. Katz senior advisor for Gameday CBD healthcare growth

By AI, Created 9:51 AM UTC, May 20, 2026, /AGP/ – American Labs appointed Dr. Richard S. Katz as senior advisor for healthcare for its Gameday CBD brand on April 29, 2026. The move is meant to strengthen clinical integration, healthcare partnerships and expansion into physical therapy, sports medicine and rehabilitation markets.

Why it matters: - Gameday CBD is pushing deeper into clinical and athletic recovery channels where healthcare credibility, compliance and product certification can influence adoption. - The appointment adds a senior advisor with direct experience in physical therapy operations, payer contracting and regulatory compliance. - The brand’s NSF Certified status is positioned as a key signal for use in clinical and competitive athletic environments.

What happened: - American Labs appointed Dr. Richard S. Katz, PT, DPT, MA, as senior advisor for healthcare for its Gameday CBD brand on April 29, 2026. - The Nevada-based company said Dr. Katz will guide clinical integration, healthcare partnerships, regulatory alignment and expansion across physical therapy, sports medicine and rehabilitation markets. - Gameday CBD is a clinical-focused topical recovery brand owned by American Labs.

The details: - Dr. Katz brings more than four decades of experience in outpatient rehabilitation, healthcare operations, payer contracting and regulatory compliance. - He has held senior executive leadership roles at some of the largest physical therapy organizations in the United States. - His work has included multi-state clinic operations, clinic acquisitions and value-based care initiatives. - Dr. Katz has worked extensively with physical therapists, athletic trainers and healthcare administrators on compliant care models. - He recently completed a six-year term as president of the California Physical Therapy Association. - American Labs said Gameday CBD is NSF Certified, which it described as reinforcing quality, compliance and suitability for clinical and athletic settings. - Robert McAllister, president of American Labs, said Katz’s experience and credibility make him an addition to the advisory team. - McAllister said Katz’s guidance will help the brand align with healthcare professional expectations while maintaining quality and compliance standards. - Dr. Katz said he is pleased to support Gameday CBD as it expands within healthcare and athletic environments. - Katz said NSF certification and professional alignment are critical for products used in clinical and performance settings.

Between the lines: - American Labs is signaling that Gameday CBD’s next phase depends on trust-building with clinicians, not just consumer marketing. - The advisory role suggests a strategy centered on institutional acceptance, where regulatory alignment and professional relationships matter as much as product performance. - The focus on physical therapy clinics, sports medicine providers and professional athletic organizations points to a B2B-style expansion path.

What’s next: - Dr. Katz is expected to advise on partnerships and market expansion as Gameday CBD grows in clinical and athletic settings. - American Labs is aiming to broaden the brand’s presence among physical therapy clinics, sports medicine providers and professional athletic organizations nationwide. - The company also says it will continue emphasizing responsible healthcare engagement and compliance-focused product development.

The bottom line: - American Labs is betting that healthcare expertise and certification can help Gameday CBD win more traction in regulated, professional recovery markets.